Thursday, March 16, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

DARPA Living Foundries 1000 Molecules Award to Duke

by Global Biodefense Staff
June 11, 2014

The Defense Advanced Research Projects Agency (DARPA) has recently awarded funding to Duke University for research in support of the Living Foundries: 1000 Molecules program.

The total award value is $2,513,015 composed of a base award for $1,585,812 and option in the amount of $927,203.

The goal of the program is to develop a first-of-its-kind biotechnology infrastructure to provide new materials, flexible capabilities, and manufacturing paradigms for national security and public health.

As a demonstration of the functionality and flexibility of the infrastructure being developed, the program aims to generate 1000 unique molecules and chemical building blocks of relevance to the Department of Defense by the end of the program’s period of performance.

Other organizations previously awarded contracts for the 1000 Molecules program include:

  • Massachusetts Institute of Technology $124,072
  • Harvard $512,930
  • Twist Bioscience Corporation $5,119,656
  • University of Illinois $239,980
  • University of Colorado $189,535
  • 20n Labs, Inc. $699,453

Living Foundries: 1000 Molecules is complementary to and builds upon the Living Foundries: Advanced Tools and Capabilities for Generalizable Platforms (ATCG) program, which is developing new tools and technologies to accelerate the biological design-build-test cycle. Together, these programs will leverage biology as a technology platform to pursue transformative applications across chemicals, materials, sensing capabilities, and therapeutics.

The DARPA Living Foundries: 1000 Molecules Program Broad Agency Announcement remains open until February 2, 2015.

Tags: AwardsDARPA

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC